United Therapeutics (NASDAQ:UTHR) Given New $315.00 Price Target at Bank of America
United Therapeutics (NASDAQ:UTHR – Get Free Report) had its price target reduced by analysts at Bank of America from $321.00 to $315.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the biotechnology company’s stock. Bank of America‘s price target indicates a potential upside of 10.09% from the company’s […]
United Therapeutics (NASDAQ:UTHR – Get Free Report) had its price target reduced by analysts at Bank of America from $321.00 to $315.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the biotechnology company’s stock. Bank of America‘s price target indicates a potential upside of 10.09% from the company’s […]
